Tower Research Capital (TRC)’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$264K Buy
14,821
+12,515
+543% +$223K 0.01% 1535
2025
Q1
$41.1K Buy
2,306
+272
+13% +$4.85K ﹤0.01% 2364
2024
Q4
$60.6K Sell
2,034
-6,669
-77% -$199K ﹤0.01% 2436
2024
Q3
$136K Sell
8,703
-16,273
-65% -$254K ﹤0.01% 1980
2024
Q2
$428K Buy
24,976
+23,233
+1,333% +$398K 0.01% 1465
2024
Q1
$27.2K Sell
1,743
-7,340
-81% -$115K ﹤0.01% 2731
2023
Q4
$136K Buy
9,083
+5,260
+138% +$78.5K ﹤0.01% 2402
2023
Q3
$61.7K Sell
3,823
-4,892
-56% -$79K ﹤0.01% 2367
2023
Q2
$362K Buy
8,715
+3,122
+56% +$130K 0.01% 1177
2023
Q1
$337K Sell
5,593
-351
-6% -$21.1K 0.01% 1073
2022
Q4
$436K Buy
5,944
+5,206
+705% +$382K 0.02% 778
2022
Q3
$57K Sell
738
-2,089
-74% -$161K ﹤0.01% 3044
2022
Q2
$196K Sell
2,827
-7,328
-72% -$508K ﹤0.01% 1780
2022
Q1
$841K Sell
10,155
-702
-6% -$58.1K 0.01% 864
2021
Q4
$815K Buy
10,857
+10,553
+3,471% +$792K 0.01% 809
2021
Q3
$35K Sell
304
-11,550
-97% -$1.33M ﹤0.01% 3241
2021
Q2
$2.63M Buy
11,854
+5,494
+86% +$1.22M 0.07% 229
2021
Q1
$841K Sell
6,360
-1,820
-22% -$241K 0.01% 868
2020
Q4
$1.42M Sell
8,180
-1,469
-15% -$254K 0.04% 347
2020
Q3
$1.07M Sell
9,649
-14,037
-59% -$1.56M 0.01% 916
2020
Q2
$1.41M Buy
+23,686
New +$1.41M 0.06% 348
2020
Q1
Sell
-4,575
Closed -$386K 3628
2019
Q4
$386K Buy
+4,575
New +$386K 0.03% 360
2019
Q3
Sell
-1,320
Closed -$83K 4384
2019
Q2
$83K Buy
1,320
+1,120
+560% +$70.4K 0.01% 1267
2019
Q1
$10K Buy
200
+100
+100% +$5K ﹤0.01% 2686
2018
Q4
$3K Sell
100
-663
-87% -$19.9K ﹤0.01% 3201
2018
Q3
$40K Buy
+763
New +$40K ﹤0.01% 1902
2018
Q1
Sell
-2,845
Closed -$57K 3710
2017
Q4
$57K Sell
2,845
-7,155
-72% -$143K 0.01% 1235
2017
Q3
$199K Buy
10,000
+6,300
+170% +$125K 0.02% 773
2017
Q2
$64K Buy
+3,700
New +$64K 0.01% 651
2016
Q3
Sell
-200
Closed -$2K 4189
2016
Q2
$2K Sell
200
-814
-80% -$8.14K ﹤0.01% 3933
2016
Q1
$15K Buy
1,014
+766
+309% +$11.3K ﹤0.01% 1569
2015
Q4
$6K Buy
+248
New +$6K ﹤0.01% 2792